Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(91 sites) United States
Kern Allergy and Medical Research- Site Number : 8400016, Bakersfield, California Modena Allergy + Asthma- Site Number : 8400038, La Jolla, California FoxHall Dermatology- Site Number : 8400042, Washington D.C., District of Columbia Palm Harbor Dermatology- Site Number : 8400024, Belleair, Florida University of Miami Hospital- Site Number : 8400011, Miami, Florida Skin Care Physicians of Georgia - Macon- Site Number : 8400030, Macon, Georgia Aeroallergy Research Laboratory- Site Number : 8400036, Savannah, Georgia Dawes Fretzin Clinical Research- Site Number : 8400007, Indianapolis, Indiana Dermatology Specialists Research (DS Research) - Kentucky- Site Number : 8400031, Louisville, Kentucky Tulane University School of Medicine- Site Number : 8400045, New Orleans, Louisiana Johns Hopkins Hospital- Site Number : 8400020, Baltimore, Maryland The Asthma and Allergy Center- Site Number : 8400014, Bellevue, Nebraska Mount Sinai - Union Square- Site Number : 8400034, New York, New York AXIS Clinicals - Fargo- Site Number : 8400037, Fargo, North Dakota Optima Research - Boardman- Site Number : 8400039, Boardman, Ohio Columbia Dermatology & Aesthetics- Site Number : 8400047, Columbia, South Carolina National Allergy and Asthma - North Charleston - Northside Drive- Site Number : 8400032, North Charleston, South Carolina Complete Dermatology - Sugar Land- Site Number : 8400046, Sugar Land, Texas Argentina
Investigational Site Number : 0320004, Rosario, Santa Fe Province Investigational Site Number : 0320008, Rosario, Santa Fe Province Investigational Site Number : 0320005, Buenos Aires Investigational Site Number : 0320001, Buenos Aires Investigational Site Number : 0320006, Buenos Aires Investigational Site Number : 0320007, Buenos Aires Investigational Site Number : 0320002, Buenos Aires Investigational Site Number : 0320003, Buenos Aires Canada
Investigational Site Number : 1240001, Calgary, Alberta Investigational Site Number : 1240008, Edmonton, Alberta Investigational Site Number : 1240002, London, Ontario Investigational Site Number : 1240003, Markham, Ontario Investigational Site Number : 1240006, Toronto, Ontario Investigational Site Number : 1240005, Montreal, Quebec Investigational Site Number : 1240004, Verdun, Quebec China
Investigational Site Number : 1560003, Beijing Investigational Site Number : 1560004, Chengdu Investigational Site Number : 1560009, Chongqing Investigational Site Number : 1560006, Guangzhou Investigational Site Number : 1560005, Guangzhou Investigational Site Number : 1560002, Hangzhou Investigational Site Number : 1560001, Shanghai Investigational Site Number : 1560011, Suzhou Investigational Site Number : 1560008, Wuhan France
Investigational Site Number : 2500001, Brest Investigational Site Number : 2500003, Nice Germany
Investigational Site Number : 2760005, Bad Bentheim Investigational Site Number : 2760002, Berlin Investigational Site Number : 2760004, Frankfurt Investigational Site Number : 2760003, Mainz Investigational Site Number : 2760001, Münster Hungary
Investigational Site Number : 3480001, Budapest Investigational Site Number : 3480009, Budapest Investigational Site Number : 3480005, Debrecen Investigational Site Number : 3480003, Szeged Investigational Site Number : 3480011, Székesfehérvár Investigational Site Number : 3480002, Zalaegerszeg Italy
Azienda Ospedaliero-Universitaria di Ferrara-Site Number : 3800007, Cona, Ferrara AUSL Toscana Centro - Presidio Ospedaliero "Piero Palagi-"Site Number : 3800005, Florence, Firenze Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico-Site Number : 3800003, Milan, Milano Investigational Site Number : 3800002, Rozzano, Milano Investigational Site Number : 3800006, Naples, Napoli Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Site Number : 3800001, Rome, Roma Azienda Ospedaliero Universitaria delle Marche-Site Number : 3800004, Ancona Japan
Investigational Site Number : 3920007, Urayasu, Chiba Investigational Site Number : 3920003, Obihiro, Hokkaido Investigational Site Number : 3920006, Sapporo, Hokkaido Investigational Site Number : 3920004, Habikino, Osaka Investigational Site Number : 3920002, Sakai, Osaka Investigational Site Number : 3920005, Izumo, Shimane Investigational Site Number : 3920001, Tachikawa, Tokyo Poland
Investigational Site Number : 6160001, Krakow, Lesser Poland Voivodeship Investigational Site Number : 6160007, Wroclaw, Lower Silesian Voivodeship Investigational Site Number : 6160003, Wroclaw, Lower Silesian Voivodeship Investigational Site Number : 6160003, Wroclaw, Lower Silesian Voivodeship Investigational Site Number : 6160008, Warsaw, Masovian Voivodeship Investigational Site Number : 6160005, Warsaw, Masovian Voivodeship South Korea
Investigational Site Number : 4100003, Busan, Busan Investigational Site Number : 4100004, Ansan-si, Gyeonggi-do Investigational Site Number : 4100005, Seoul, Seoul-teukbyeolsi Investigational Site Number : 4100002, Seoul, Seoul-teukbyeolsi Investigational Site Number : 4100006, Seoul, Seoul-teukbyeolsi Investigational Site Number : 4100001, Seoul, Seoul-teukbyeolsi Investigational Site Number : 4100007, Seoul, Seoul-teukbyeolsi Spain
Investigational Site Number : 7240003, Barcelona, Barcelona [Barcelona] Investigational Site Number : 7240006, Barcelona, Catalunya [Cataluña] Investigational Site Number : 7240001, Pontevedra, Pontevedra [Pontevedra] Investigational Site Number : 7240005, Alicante Investigational Site Number : 7240004, Córdoba Taiwan
Investigational Site Number : 1580003, Kaohsiung City Investigational Site Number : 1580004, New Taipei City Investigational Site Number : 1580001, Taipei Investigational Site Number : 1580002, Taoyuan